Literature DB >> 30020751

The development of diabetes complications in GP-centered healthcare.

Kateryna Karimova1, Lorenz Uhlmann, Marc Hammer, Corina Guethlin, Ferdinand M Gerlach, Martin Beyer.   

Abstract

OBJECTIVES: To compare the development of diabetes complications, measured in terms of clinical end points, of patients enrolled in general practitioner (GP)-centered healthcare (Hausarztzentrierte Versorgung [HZV]) and patients in usual GP care (non-HZV) over 4 years. STUDY
DESIGN: Retrospective closed cohort study based on German claims data.
METHODS: The main end points in our evaluation were dialysis, blindness, amputation, stroke, myocardial infarction, cardiovascular disease, hypoglycemia, and mortality. We used Cox proportional hazards regression models for multivariable analysis.
RESULTS: We included 217,964 patients in our study: 119,355 were enrolled in HZV and 98,609 were in non-HZV. Compared with non-HZV, the HZV group had a 15.6% lower risk of requiring dialysis during the 4 years of observation. Risks were also lower in the HZV group for all other end points except mortality.
CONCLUSIONS: The results of the present study indicate that GP-centered healthcare is associated with a delay in the occurrence of serious diabetes complications and reduces the risk of diabetes complications. This may be because GP-centered care is associated with improved coordination of care.

Entities:  

Mesh:

Year:  2018        PMID: 30020751

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  2 in total

1.  Intensified ambulatory cardiology care: effects on mortality and hospitalisation-a comparative observational study.

Authors:  Ralph F Bosch; Martin Beyer; Olga A Sawicki; Angelina Mueller; Anastasiya Glushan; Thorben Breitkreuz; Felix S Wicke; Kateryna Karimova; Ferdinand M Gerlach; Michel Wensing; Norbert Smetak
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

2.  Strong and sustainable primary healthcare is associated with a lower risk of hospitalization in high risk patients.

Authors:  Olga A Sawicki; Angelina Mueller; Renate Klaaßen-Mielke; Anastasiya Glushan; Ferdinand M Gerlach; Martin Beyer; Michel Wensing; Kateryna Karimova
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.